Variant report
Variant | esv1825720 |
---|---|
Chromosome Location | chr4:93847904-93869564 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:93846312..93847841-chr4:93851226..93853929,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547664453 | chr4:93852024-93852025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538231473 | chr4:93852053-93852054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558507065 | chr4:93852054-93852055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs574248835 | chr4:93852057-93852058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541733701 | chr4:93852058-93852059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535372670 | chr4:93852067-93852068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs116181052 | chr4:93852073-93852074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113384661 | chr4:93852101-93852102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543942474 | chr4:93852107-93852108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142093930 | chr4:93852127-93852128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533111735 | chr4:93852132-93852133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532559798 | chr4:93852136-93852137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190330091 | chr4:93852139-93852140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559689671 | chr4:93852153-93852154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527635283 | chr4:93852206-93852207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181369229 | chr4:93852217-93852218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567134844 | chr4:93852221-93852222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35197316 | chr4:93852260-93852261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs398107659 | chr4:93852267-93852268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs377018840 | chr4:93852268-93852269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185251643 | chr4:93852275-93852276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542934521 | chr4:93852285-93852286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191193790 | chr4:93852295-93852296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201696542 | chr4:93852299-93852300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146215177 | chr4:93852306-93852307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538714590 | chr4:93852374-93852375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74933247 | chr4:93852375-93852376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565664736 | chr4:93852396-93852397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571825174 | chr4:93852399-93852400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150135727 | chr4:93864282-93864283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188802938 | chr4:93864339-93864340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112645717 | chr4:93864340-93864341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555336485 | chr4:93864356-93864357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575533536 | chr4:93864382-93864383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145578411 | chr4:93864386-93864387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564354643 | chr4:93864392-93864393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183522744 | chr4:93864404-93864405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531580547 | chr4:93864456-93864457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540798280 | chr4:93864472-93864473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560417661 | chr4:93864482-93864483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529380564 | chr4:93864498-93864499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549155538 | chr4:93864508-93864509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569227064 | chr4:93864517-93864518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs187472013 | chr4:93864534-93864535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557804624 | chr4:93864548-93864549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs550862080 | chr4:93864563-93864564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570684121 | chr4:93864568-93864569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539285284 | chr4:93864570-93864571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553120893 | chr4:93864575-93864576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567084364 | chr4:93864580-93864581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 20841430 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:93852000-93852400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr4:93864200-93866800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr4:93864400-93874200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr4:93865400-93865800 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
5 | chr4:93865800-93895400 | Weak transcription | H1 Cell Line | embryonic stem cell |